基因组不稳定性
旁观者效应
间充质干细胞
骨髓
生物
癌症研究
肿瘤坏死因子α
免疫学
DNA损伤
细胞生物学
遗传学
DNA
作者
Yiming Zhang,Liying Zhang,Yangyang Li,Heng Zhou,Zhiming Miao,Zhiwei Liu,Gu-Cheng Zhou,Ting Zhou,Fan Niu,Jing Li,Tao Hong,Jinpeng He,Nan Ding,Yanan Zhang,Junrui Hua,Jufang Wang,Yongqi Liu
标识
DOI:10.1089/ars.2022.0072
摘要
Aims: Radiation by-radiation effect (RIBE) can induce the genomic instability of bone marrow mesenchymal stem cells (BMSCs) adjacent to lung cancer, and this effect not only exists in the short-term, but also accompanies it in the long-term, but its specific mechanism is not clear. Our goal is to explore the similarities and differences in the mechanism of genomic damage in tumor-associated BMSCs induced by short-term and long-term RIBE, and to provide a theoretical basis for adjuvant drugs for protection against RIBE at different clinical time periods. Results: We found that both short- and long-term RIBE induced genomic instability. We could show a high expression of TGF-β1, TNF-α, and HIF-1α in tumor-associated BMSCs after short-term RIBE whereas only TNF-α and HIF-1α expression was increased in long-term RIBE. We further confirmed that genomic instability is associated with the activation of the HIF-1α pathway and that this is mediated by TNF-α and TGF-β1. In addition, we found differences in the mechanisms of genomic instability in the considered RIBE windows of analysis. In short-term RIBE, both TNF-α and TGF-β1 play a role, whereas only TNF-α plays a decisive role in long-term RIBE. In addition, there were differences in BMSC recruitment and genomic instability of different tissues with a more pronounced expression in tumor and bone marrow than compared to lung. Innovation and Conclusion: We could show dynamic changes in the expression of the cytokines TGF-β1 and TNF-α during short- and long-term RIBE. The differential expression of the two is the key to causing the genomic damage of tumor-associated BMSCs in the considered windows of analysis. Therefore, these results may serve as a guideline for the administration of radiation protection adjuvant drugs at different clinical stages. Antioxid. Redox Signal. 38, 747–767.
科研通智能强力驱动
Strongly Powered by AbleSci AI